chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: CHILLS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 08-MAR-2021 08:00 a.m. for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 08-MAR-2021, the patient experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills. This report was non-serious.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: HEADACHE; This spontaneous report received from a patient concerned a 64 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non-alcoholic user, and non-smoker, and other pre-existing medical conditions included the patient did not have any history of drug abuse or illicit drug use. The patient experienced drug allergy when treated with amoxicillin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 08-MAR-2021 11:00 to Left Deltoid for prophylactic vaccination. The batch number was not reported and has been reported. No concomitant medications were reported. On 08-MAR-2021 22:00, the subject experienced headache. On 09-MAR-2021, treatment medications included: acetylsalicylic acid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache on 09-MAR-2021. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: FEVER OF 101.6; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022, and expiry: not reported) dose was not reported, administered on 08-MAR-2021 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced fever of 101.6. Laboratory data (dates unspecified) included: Body temperature 101.6 (not reported). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever of 101.6. This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Pain
Clinical narrative: CHILLS; BODY ACHES; FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, and batch number: 1802072 expiry: UNKNOWN) .5 ml, administered on 07-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced body aches. On MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from chills, body aches, and fatigue. This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Feeling hot, Photosensitivity reaction, SARS-CoV-2 test, Suspected COVID-19, Vaccination failure
Clinical narrative: CHILLS; BODY ACHES; FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, and batch number: 1802072 expiry: UNKNOWN) .5 ml, administered on 07-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced body aches. On MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from chills, body aches, and fatigue. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Muscular weakness, Speech disorder
Clinical narrative: HEADACHE; DIFFICULTY SPEAKING; WEAKNESS ON THE RIGHT ARM; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 08-MAR-2021 to Left Arm for prophylactic vaccination. The batch number was not reported and has been requested No concomitant medications were reported. On 08-MAR-2021, the patient experienced headache. On 08-MAR-2021, the patient experienced difficulty speaking. On 08-MAR-2021, the patient experienced weakness on the right arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from weakness on the right arm, and the outcome of headache and difficulty speaking was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chest pain, Chills, Discomfort, Headache
Clinical narrative: PRETTY SEVERE DISCOMFORT ALONG THE SPINE BETWEEN THE SCAPULA; CHILLS; DULL HEADACHE; BURNING IN CHEST; BURNING IN SHOULDER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022, and batch number: 1805022 expiry: UNKNOWN) .5 ml, administered on 07-MAR-2021 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported.  On 07-MAR-2021, the subject experienced burning in chest. On 07-MAR-2021, the subject experienced burning in shoulder. On 08-MAR-2021, the subject experienced pretty severe discomfort along the spine between the scapula. On 08-MAR-2021, the subject experienced chills. On 08-MAR-2021, the subject experienced dull headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from burning in chest on 07-MAR-2021, and chills, was recovering from burning in shoulder, and had not recovered from pretty severe discomfort along the spine between the scapula, and dull headache. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dyspnoea, Feeling cold, Feeling hot
Clinical narrative: FEELING COLD; SHIVERING; SHORTNESS OF BREATH; FEELING WARM AND HOTNESS WITH A TEMPERATURE OF 95.5; This spontaneous report received from a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802070, and batch number: 1802070 expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported. On 06-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 95.5 F. On 06-MAR-2021 08:00, the subject experienced feeling cold. On 06-MAR-2021 08:00, the subject experienced shivering. On 06-MAR-2021 08:00, the subject experienced shortness of breath. On 06-MAR-2021 08:00, the subject experienced feeling warm and hotness with a temperature of 95.5. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from shivering on MAR-2021, was recovering from shortness of breath, and had not recovered from feeling cold, and feeling warm and hotness with a temperature of 95.5. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Dysgeusia, Headache, Myalgia
Clinical narrative: BITTERNESS IN MOUTH; MUSCLE ACHES; HEADACHE; CHILLS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number was not reported) dose was not reported, administered on 06-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 06-MAR-2021, the patient experienced muscle aches. On 06-MAR-2021, the patient experienced headache. On 06-MAR-2021, the patient experienced chills. On 09-MAR-2021, the patient experienced bitterness in mouth. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from muscle aches, headache, and chills on 08-MAR-2021, and had not recovered from bitterness in mouth. This report was non-serious.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Glycosylated haemoglobin abnormal, Headache, Lethargy
Clinical narrative: LETHARGIC; VOMITING; SHAKING; FEVER; DIARRHEA; CHILLS; HEADACHE; NAUSEA; This spontaneous report received from a patient concerned a 69 year old female. The patient's weight was 125 pounds, and height was 64 inches. The patient's concurrent conditions included sulfa allergy, gluten allergy, dairy allergy, non alcohol user, and non smoker, and other pre-existing medical conditions included the patient did not had drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805020, and batch number: 1805020 expiry: UNKNOWN) dose was not reported, administered on 06-MAR-2021 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported. On 01-JUL-2020, Laboratory data included: Glycosylated hemoglobin abnormal (NR: not provided) UNKNOWN. On 06-MAR-2021, the subject experienced fever. On 06-MAR-2021, the subject experienced headache. On 06-MAR-2021, the subject experienced lethargic. On 06-MAR-2021, the subject experienced nausea. On 06-MAR-2021, the subject experienced vomiting. On 06-MAR-2021, the subject experienced chills. On 06-MAR-2021, the subject experienced shaking. On 06-MAR-2021, the subject experienced diarrhea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nausea, vomiting, chills, shaking, and diarrhea on 06-MAR-2021, and had not recovered from fever, headache, and lethargic. This report was non-serious.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Tremor, Vomiting
Clinical narrative: LETHARGIC; VOMITING; SHAKING; FEVER; DIARRHEA; CHILLS; HEADACHE; NAUSEA; This spontaneous report received from a patient concerned a 69 year old female. The patient's weight was 125 pounds, and height was 64 inches. The patient's concurrent conditions included sulfa allergy, gluten allergy, dairy allergy, non alcohol user, and non smoker, and other pre-existing medical conditions included the patient did not had drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805020, and batch number: 1805020 expiry: UNKNOWN) dose was not reported, administered on 06-MAR-2021 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported. On 01-JUL-2020, Laboratory data included: Glycosylated hemoglobin abnormal (NR: not provided) UNKNOWN. On 06-MAR-2021, the subject experienced fever. On 06-MAR-2021, the subject experienced headache. On 06-MAR-2021, the subject experienced lethargic. On 06-MAR-2021, the subject experienced nausea. On 06-MAR-2021, the subject experienced vomiting. On 06-MAR-2021, the subject experienced chills. On 06-MAR-2021, the subject experienced shaking. On 06-MAR-2021, the subject experienced diarrhea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nausea, vomiting, chills, shaking, and diarrhea on 06-MAR-2021, and had not recovered from fever, headache, and lethargic. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia
Clinical narrative: MUSCLE PAIN IN ARM OF SHOT; TIREDNESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018, and batch number: 1805018 expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 14:45 to Right Arm for prophylactic vaccination. No concomitant medications were reported. On 07-MAR-2021, the subject experienced muscle pain in arm of shot. On 07-MAR-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from muscle pain in arm of shot, and tiredness on 08-MAR-2021. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Illness, Pain
Clinical narrative: EXTREMELY SICK FOR 10 HOURS; PAIN; FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 05-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced extremely sick for 10 hours. On MAR-2021, the subject experienced pain. On MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from pain on 08-MAR-2021, was recovering from extremely sick for 10 hours, and had not recovered from fatigue. This report was non-serious.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Headache, Pyrexia
Clinical narrative: BACKACHE; HEADACHE; FEVER; CHILLS; This spontaneous report received from a patient concerned a 25 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient was not pregnant at the time of event reporting and the patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 08-MAR-2021 to Left Arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 09-MAR-2021, the subject experienced backache. On 09-MAR-2021, the subject experienced headache. On 09-MAR-2021, the subject experienced fever. On 09-MAR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from backache, headache, fever, and chills. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia
Clinical narrative: HEADACHE; MUSCLE PAIN; TIREDNESS; This spontaneous report received from a patient concerned an 18 year old female. The patient's weight was 65 kilograms, and height was 71 inches. The patient's concurrent conditions included von willebrand disease, abstains from alcohol, non-smoker, and allergic to nsaids, and other pre-existing medical conditions included no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022, and batch number: 1805022 expiry: UNKNOWN) .5 ml, administered on 08-MAR-2021 03:11 to Right Deltoid for prophylactic vaccination. No concomitant medications were reported. On 08-MAR-2021, the subject experienced headache. On 08-MAR-2021, the subject experienced muscle pain. On 08-MAR-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, muscle pain, and tiredness. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia
Clinical narrative: BODY ACHE; CHIILS; FEVER; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802070) dose was not reported, administered on 06-MAR-2021 17:30 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 07-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 100 Degree F. On 07-MAR-2021 06:00, the subject experienced body ache. On 07-MAR-2021 06:00, the subject experienced chiils. On 07-MAR-2021 06:00, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chiils, and fever, and the outcome of body ache was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Dizziness, Headache
Clinical narrative: SORE ARM; FEVER; REALLY BAD HEADACHE; BODY ACHE; JOINT ACHE; NAUSEA; DIZZINESS; CHILLS; LOW ENERGY; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018, and batch number: 1805018 expiry: UNKNOWN) .5 ml, administered on 05-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 05-MAR-2021, the subject experienced sore arm. On 05-MAR-2021, the subject experienced fever. On 05-MAR-2021, the subject experienced really bad headache. On 05-MAR-2021, the subject experienced body ache. On 05-MAR-2021, the subject experienced joint ache. On 05-MAR-2021, the subject experienced nausea. On 05-MAR-2021, the subject experienced dizziness. On 05-MAR-2021, the subject experienced chills. On 05-MAR-2021, the subject experienced low energy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm, fever, really bad headache, body ache, joint ache, nausea, dizziness, and chills on 07-MAR-2021, and low energy on 08-MAR-2021. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain, Pain in extremity, Pyrexia
Clinical narrative: SORE ARM; FEVER; REALLY BAD HEADACHE; BODY ACHE; JOINT ACHE; NAUSEA; DIZZINESS; CHILLS; LOW ENERGY; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018, and batch number: 1805018 expiry: UNKNOWN) .5 ml, administered on 05-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 05-MAR-2021, the subject experienced sore arm. On 05-MAR-2021, the subject experienced fever. On 05-MAR-2021, the subject experienced really bad headache. On 05-MAR-2021, the subject experienced body ache. On 05-MAR-2021, the subject experienced joint ache. On 05-MAR-2021, the subject experienced nausea. On 05-MAR-2021, the subject experienced dizziness. On 05-MAR-2021, the subject experienced chills. On 05-MAR-2021, the subject experienced low energy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm, fever, really bad headache, body ache, joint ache, nausea, dizziness, and chills on 07-MAR-2021, and low energy on 08-MAR-2021. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Accidental exposure to product
Clinical narrative: OCULAR EXPOSURE TO VACCINE WHILE PREPPING FOR ADMINISTRATION; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had unknown medical history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) .5 ml, administered on 08-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 08-MAR-2021, the subject experienced ocular exposure to vaccine while prepping for administration. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of ocular exposure to vaccine while prepping for administration was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site erythema, Injection site pain, Injection site rash, Injection site swelling
Clinical narrative: SWELLING IN LEFT ARM AT THE INJECTION SITE; REDNESS AT INJECTION SITE; HURTING AT INJECTION SITE; RASH ON LEFT ARM AT THE INJECTION SITE; CHILLS; FEVER; This spontaneous report received from a patient concerned a 29 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 to Left Arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced fever. On 08-MAR-2021, the subject experienced redness at injection site. On 08-MAR-2021, the subject experienced hurting at injection site. On 08-MAR-2021, the subject experienced rash on left arm at the injection site. On 09-MAR-2021, the subject experienced swelling in left arm at the injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and fever, and had not recovered from redness at injection site, hurting at injection site, rash on left arm at the injection site, and swelling in left arm at the injection site. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: SWELLING IN LEFT ARM AT THE INJECTION SITE; REDNESS AT INJECTION SITE; HURTING AT INJECTION SITE; RASH ON LEFT ARM AT THE INJECTION SITE; CHILLS; FEVER; This spontaneous report received from a patient concerned a 29 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 to Left Arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced fever. On 08-MAR-2021, the subject experienced redness at injection site. On 08-MAR-2021, the subject experienced hurting at injection site. On 08-MAR-2021, the subject experienced rash on left arm at the injection site. On 09-MAR-2021, the subject experienced swelling in left arm at the injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and fever, and had not recovered from redness at injection site, hurting at injection site, rash on left arm at the injection site, and swelling in left arm at the injection site. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Feeling hot, Headache
Clinical narrative: WEAKNESS; NO HIGH BLOOD PRESSURE; RAISED DOTS ON  FACE; RAISED DOTS ON CHEST; FEVER; CHILLS; HEADACHE; RUNNY NOSE; CHEST WARM TO TOUCH; This spontaneous report received from a patient concerned a 65 year old female. The patient's height, and weight were not reported. The patient's past medical history included heart failure, and sulfa drug, and concurrent conditions included smoker, and influenza. The patient was previously treated with losartan for heart failure, spironolactone for heart failure, metoprolol for heart failure, furosemide for heart failure, and levothyroxine for heart failure. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022, and batch number: 1805022 expiry: UNKNOWN) .5 ml, administered on 08-MAR-2021 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced runny nose. On 09-MAR-2021, the subject experienced chest warm to touch. On 09-MAR-2021, the subject experienced headache. On 09-MAR-2021 12:00, the subject experienced raised dots on face. On 09-MAR-2021 12:00, the patient experienced raised dots on chest. On 09-MAR-2021 12:00, the patient experienced fever. On 09-MAR-2021 12:00, the patient experienced chills. On an unspecified date, the patient experienced weakness, and no high blood pressure. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) low (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, chills, and headache, had not recovered from raised dots on face, runny nose, weakness, chest warm to touch, and raised dots on chest, and the outcome of no high blood pressure was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Pyrexia, Rash, Rhinorrhoea, Skin disorder
Clinical narrative: WEAKNESS; NO HIGH BLOOD PRESSURE; RAISED DOTS ON  FACE; RAISED DOTS ON CHEST; FEVER; CHILLS; HEADACHE; RUNNY NOSE; CHEST WARM TO TOUCH; This spontaneous report received from a patient concerned a 65 year old female. The patient's height, and weight were not reported. The patient's past medical history included heart failure, and sulfa drug, and concurrent conditions included smoker, and influenza. The patient was previously treated with losartan for heart failure, spironolactone for heart failure, metoprolol for heart failure, furosemide for heart failure, and levothyroxine for heart failure. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022, and batch number: 1805022 expiry: UNKNOWN) .5 ml, administered on 08-MAR-2021 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced runny nose. On 09-MAR-2021, the subject experienced chest warm to touch. On 09-MAR-2021, the subject experienced headache. On 09-MAR-2021 12:00, the subject experienced raised dots on face. On 09-MAR-2021 12:00, the patient experienced raised dots on chest. On 09-MAR-2021 12:00, the patient experienced fever. On 09-MAR-2021 12:00, the patient experienced chills. On an unspecified date, the patient experienced weakness, and no high blood pressure. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) low (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, chills, and headache, had not recovered from raised dots on face, runny nose, weakness, chest warm to touch, and raised dots on chest, and the outcome of no high blood pressure was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: CHILLS; TIRED; HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802068, and batch number: 1802068 expiry: UNKNOWN) .5 ml, administered on 05-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 05-MAR-2021, the subject experienced chills. On 05-MAR-2021, the subject experienced tired. On 05-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, tired, and headache on 07-MAR-2021. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: BIT OF A FEVER; FEELING VERY TIRED; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 09:00 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 06-MAR-2021 23:00, the subject experienced bit of a fever. On 06-MAR-2021 23:00, the subject experienced feeling very tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the bit of a fever and feeling very tired was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: HIVES ON BACK; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802070, and batch number: 1802070 expiry: UNKNOWN) .5 ml, administered on 09-MAR-2021 to Right Deltoid for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced hives on back. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from hives on back. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, Chills, Headache, Injection site pain
Clinical narrative: HEADACHE; INJECTION SITE PAIN; CHILLS; MUSCLE PAIN; TEMPERATURE CHANGE +2 DEGREES HIGHER THAN NORMAL TEMPERATURE; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNWON expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, Laboratory data included: Body temperature (NR: not provided) plus 2 degrees higher than normal temperature. On 06-MAR-2021, the subject experienced headache. On 06-MAR-2021, the subject experienced injection site pain. On 06-MAR-2021, the subject experienced chills. On 06-MAR-2021, the subject experienced muscle pain. On 06-MAR-2021, the subject experienced temperature change +2 degrees higher than normal temperature. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, injection site pain, chills, muscle pain and temperature change +2 degrees higher than normal temperature was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: HEADACHE; INJECTION SITE PAIN; CHILLS; MUSCLE PAIN; TEMPERATURE CHANGE +2 DEGREES HIGHER THAN NORMAL TEMPERATURE; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNWON expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, Laboratory data included: Body temperature (NR: not provided) plus 2 degrees higher than normal temperature. On 06-MAR-2021, the subject experienced headache. On 06-MAR-2021, the subject experienced injection site pain. On 06-MAR-2021, the subject experienced chills. On 06-MAR-2021, the subject experienced muscle pain. On 06-MAR-2021, the subject experienced temperature change +2 degrees higher than normal temperature. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, injection site pain, chills, muscle pain and temperature change +2 degrees higher than normal temperature was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Injection site nodule, Injection site swelling, Peripheral swelling
Clinical narrative: HARD KNOT AT INJECTION SITE; SWELLING IN ARM; SWELLING INJECTION SITE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1801018, and batch number: 1801018 expiry: UNKNOWN) .5 ml, administered on 05-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 06-MAR-2021, the subject experienced swelling in arm. On 06-MAR-2021, the subject experienced swelling injection site. On 07-MAR-2021, the subject experienced hard knot at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from swelling in arm, had not recovered from hard knot at injection site, and the outcome of swelling injection site was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia
Clinical narrative: HEADACHE; CHILLS; MYALGIA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802068, and batch number: 1802068 expiry: UNKNOWN) .5 ml, administered on MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-MAR-2021, the subject experienced chills. On 07-MAR-2021, the subject experienced myalgia. On 08-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and myalgia on 08-MAR-2021, and had not recovered from headache. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: FEVER; BODY ACHES; CHILLS; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, expiry: UNKNOWN) .5 ml, administered on 08-MAR-2021 11:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 09-MAR-2021, the subject experienced fever. On 09-MAR-2021, the subject experienced body aches. On 09-MAR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, and chills on 09-MAR-2021, and had not recovered from fever. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: FEVER; PAIN IN LEGS; This spontaneous report received from a parent concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included allergic to dogs and cats, pollen allergy, some raw fruits allergy, and vegetables allergy, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 07-MAR-2021 11:00 to Left Arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 07-MAR-2021 20:00, the subject experienced fever. On 07-MAR-2021 20:00, the subject experienced pain in legs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, and pain in legs. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: PAIN AT INJECTION SITE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no previous medical conditions. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805020, and batch number: 1805020 expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 10:40 to Right Arm for prophylactic vaccination. No concomitant medications were reported. On 06-MAR-2021, the subject experienced pain at injection site. Treatment medications included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from pain at injection site. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Nausea, Pyrexia, Vomiting
Clinical narrative: NAUSEA; CHILLS; FEVER; EMESIS 5 TIMES OF YELLOW FLUID; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805029, and batch number: 1805029 expiry: UNKNOWN) .5 ml, administered on 08-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced nausea. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced fever. On MAR-2021, the subject experienced emesis 5 times of yellow fluid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nausea on 09-MAR-2021, and chills, fever, and emesis 5 times of yellow fluid on MAR-2021. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Headache, Oropharyngeal pain, Pyrexia
Clinical narrative: HEADACHE; FEVER; SORE THROAT; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included covid-19 pneumonia. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 07-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 07-MAR-2021, the subject experienced headache. On 07-MAR-2021, the subject experienced fever. On 07-MAR-2021, the subject experienced sore throat. Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, and fever, and the outcome of sore throat was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: STARTED RASH ON ONE ARM, BACK, NECK, OTHER ARM; ITCHING; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805025, and batch number: 1805025 expiry: UNKNOWN) .5 ml, administered on 08-MAR-2021 17:30 to left arm for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced itching. On 09-MAR-2021 02:00, the subject experienced started rash on one arm, back, neck, other arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the itching and started rash on one arm, back, neck, other arm was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: CHILLS; HEADACHE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018 expiry: UNKNOWN) .5 ml, administered on 07-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-MAR-2021, the subject experienced chills. On 07-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, and headache. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Pain, Pyrexia
Clinical narrative: HIGH FEVER; ACHY; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) .5 ml, administered on 08-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 08-MAR-2021, the subject experienced high fever. On 08-MAR-2021, the subject experienced achy. Laboratory data included: Body temperature (NR: not provided) 102.3 F. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from high fever, and achy. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Fatigue, Headache, Injection site pain, Injection site swelling
Clinical narrative: FEVER; MUSCLE ACHES; INTERMITTENT HEADACHES; INTERMITTANT NAUSEA; SORE ARM AT VACCINATION SITE; SWOLLEN ARM AT VACCINATION SITE (LUA); BODY ACHE; FATIGUE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included celiac disease, high blood pressure, and allergic to penicillin, and other pre-existing medical conditions included patient has a sore and swollen area at vaccine administration arm site that was similar to what she experiences with the annual flu shot. The patient experienced drug allergy when treated with hydrochlorothiazide. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018, and batch number: 1805018 expiry: 25-MAY-2021) .5 ml, administered on 05-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 06-MAR-2021, the subject experienced fever. On 06-MAR-2021, the subject experienced muscle aches. On 06-MAR-2021, the subject experienced intermittent headaches. On 06-MAR-2021, the subject experienced intermittant nausea. On 06-MAR-2021, the subject experienced sore arm at vaccination site. On 06-MAR-2021, the subject experienced swollen arm at vaccination site (lua). On 06-MAR-2021, the subject experienced body ache. On 06-MAR-2021, the subject experienced fatigue. Laboratory data included: Body temperature increased (NR: not provided) 101.5 F. Treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, muscle aches, intermittent headaches, intermittant nausea, sore arm at vaccination site, swollen arm at vaccination site (lua), body ache, and fatigue. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pain, Pyrexia
Clinical narrative: FEVER; MUSCLE ACHES; INTERMITTENT HEADACHES; INTERMITTANT NAUSEA; SORE ARM AT VACCINATION SITE; SWOLLEN ARM AT VACCINATION SITE (LUA); BODY ACHE; FATIGUE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included celiac disease, high blood pressure, and allergic to penicillin, and other pre-existing medical conditions included patient has a sore and swollen area at vaccine administration arm site that was similar to what she experiences with the annual flu shot. The patient experienced drug allergy when treated with hydrochlorothiazide. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018, and batch number: 1805018 expiry: 25-MAY-2021) .5 ml, administered on 05-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 06-MAR-2021, the subject experienced fever. On 06-MAR-2021, the subject experienced muscle aches. On 06-MAR-2021, the subject experienced intermittent headaches. On 06-MAR-2021, the subject experienced intermittant nausea. On 06-MAR-2021, the subject experienced sore arm at vaccination site. On 06-MAR-2021, the subject experienced swollen arm at vaccination site (lua). On 06-MAR-2021, the subject experienced body ache. On 06-MAR-2021, the subject experienced fatigue. Laboratory data included: Body temperature increased (NR: not provided) 101.5 F. Treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, muscle aches, intermittent headaches, intermittant nausea, sore arm at vaccination site, swollen arm at vaccination site (lua), body ache, and fatigue. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN) .5 ml, administered on 05-MAR-2021 to Left Deltoid for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 06-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever. This report was non-serious.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Pyrexia
Clinical narrative: FEVER OF 100.4; HEADACHE; This spontaneous report received from a patient concerned a 72 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non smoker, penicillin allergy, and sulfa allergy, and other pre-existing medical conditions included patient is healthy and no current health conditions. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018, and batch number: 1805018 expiry: UNKNOWN) .5 ml, administered on 08-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-MAR-2021, the subject experienced fever of 100.4. On 09-MAR-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 100.4 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever of 100.4, and headache. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as the case is assessed as non serious.